Free Trial

Aspira Women's Health Q3 2023 Earnings Report

Aspira Women's Health logo
$0.22 -0.01 (-4.41%)
As of 02/21/2025 03:58 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Aspira Women's Health EPS Results

Actual EPS
-$0.48
Consensus EPS
-$0.43
Beat/Miss
Missed by -$0.05
One Year Ago EPS
N/A

Aspira Women's Health Revenue Results

Actual Revenue
$2.22 million
Expected Revenue
$2.90 million
Beat/Miss
Missed by -$680.00 thousand
YoY Revenue Growth
N/A

Aspira Women's Health Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Aspira Women's Health Earnings Headlines

$5,000 DOGE check?
Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a portion of the savings DOGE makes in Federal cuts could be funneled back to taxpayers. The media was quick to dub it a DOGE Dividend, with claims circulating that we could all receive a $5,000 check in the mail.
Aspira Women’s Health appoints Ellen Beausang to board of directors
See More Aspira Women's Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Aspira Women's Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aspira Women's Health and other key companies, straight to your email.

About Aspira Women's Health

Aspira Women's Health (NASDAQ:AWH), Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.

View Aspira Women's Health Profile

More Earnings Resources from MarketBeat